Emergent BioSolutions Inc Share Price Today: Live Updates & Key Insights

Emergent BioSolutions Inc share price today is $8.19, up 1.36%. The stock opened at $8.14 against the previous close of $8.08, with an intraday high of $8.22 and low of $7.975.

Emergent BioSolutions Inc Share Price Chart

Emergent BioSolutions Inc

us-stock
To Invest in {{usstockname}}
us-stock

Emergent BioSolutions Inc Share Price Performance

$8.19 0.0136(1.36%) EBS at 23 Mar 2026 12:48 PM Drug Manufacturers - Specialty & Generic
Lowest Today 7.975
Highest Today 8.22
Today’s Open 8.14
Prev. Close 8.08
52 Week High 14.06
52 Week Low 4.02
Day’s Range: Low 7.975 High 8.22
52-Week Range: Low 4.02 High 14.06
1 day return -
1 Week return -1.38
1 month return -25.11
3 month return -35.93
6 month return +0.36
1 year return +42.98
3 year return +5.26
5 year return -91.36
10 year return -

Emergent BioSolutions Inc Institutional Holdings

BlackRock Inc 8.23

Oak Hill Advisors LP 6.98

Vanguard Group Inc 6.86

State Street Corp 4.72

American Century Companies Inc 4.71

Dimensional Fund Advisors, Inc. 4.35

Avantis US Small Cap Value ETF 3.88

Charles Schwab Investment Management Inc 3.13

Vanguard Total Stock Mkt Idx Inv 3.11

State Street® SPDR® S&P® Biotech ETF 2.86

iShares Russell 2000 ETF 2.50

Palisade Capital Management LLc 2.44

Geode Capital Management, LLC 2.41

Acadian Asset Management LLC 2.27

Schwab Fundamental U.S. Small CompanyETF 1.92

Jain Global LLC 1.82

LSV Asset Management 1.74

Palisade Small Cap Core Equity 1.66

Connor Clark & Lunn Inv Mgmt Ltd 1.50

Prescott Group Capital Management LLC 1.49

Marshall Wace Asset Management Ltd 1.44

D. E. Shaw & Co LP 1.40

Northern Trust Corp 1.23

The Goldman Sachs Group Inc 1.20

Renaissance Technologies Corp 1.11

Vanguard Institutional Extnd Mkt Idx Tr 1.09

Morgan Stanley - Brokerage Accounts 1.02

Fidelity Small Cap Index 0.99

Vanguard Strategic Equity Inv 0.90

iShares Russell 2000 Value ETF 0.88

iShares Biotechnology ETF 0.73

Dimensional US Targeted Value ETF 0.66

DFA US Small Cap Value I 0.64

DFA US Targeted Value I 0.62

Federated Hermes MDT SCC Institutional 0.61

Federated Hermes MDT Small Cap Core IS 0.61

State St Russell Sm/Mid Cp® Indx SL Cl I 0.56

Fidelity Extended Market Index 0.54

Schwab US Small-Cap ETF™ 0.49

Vanguard Russell 2000 ETF 0.48

Emergent BioSolutions Inc Market Status

Strong Buy: 1

Buy: 1

Hold: 0

Sell: 1

Strong Sell: 0

Emergent BioSolutions Inc Fundamentals

Market Cap 430.14 M

PB Ratio 0.8113

PE Ratio 8.7128

Enterprise Value 790.70 M

Total Assets 1318.60 M

Volume 2027340

Emergent BioSolutions Inc Company Financials

Annual Revenue FY25:742900000 742.9M, FY23:1120900000 1120.9M, FY22:1120900000 1120.9M, FY21:1792700000 1792.7M, FY20:1555400000 1555.4M

Annual Profit FY25:null 0.0M, FY23:427200000 427.2M, FY22:427200000 427.2M, FY21:1035200000 1035.2M, FY20:1031400000 1031.4M

Annual Net worth FY25:52600000 52.6M, FY23:-223800000 -223.8M, FY22:-223800000 -223.8M, FY21:230900000 230.9M, FY20:305100000 305.1M

Quarterly Revenue Q4/2025:148700000 148.7M, Q3/2025:231100000 231.1M, Q2/2025:140900000 140.9M, Q1/2025:222200000 222.2M, Q3/2024:293800000 293.8M

Quarterly Profit Q4/2025:-319500000 -319.5M, Q3/2025:139400000 139.4M, Q2/2025:60700000 60.7M, Q1/2025:119400000 119.4M, Q3/2024:164200000 164.2M

Quarterly Net worth Q4/2025:-54600000 -54.6M, Q3/2025:51200000 51.2M, Q2/2025:-12000000 -12.0M, Q1/2025:68000000 68.0M, Q3/2024:114800000 114.8M

About Emergent BioSolutions Inc & investment objective

Company Information Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates through Commercial Products, MCM Products, and All Other Revenues segments. The company offers ACAM2000, a smallpox and mpox vaccine; Anthrax Immune Globulin Intravenous (ANTHRASIL), a polyclonal antibody therapeutic for the treatment of inhalational anthrax; Botulism Antitoxin Heptavalent (BAT), an equine plasma antitoxin for the treatment of symptomatic botulism; BioThrax, an anthrax vaccine; CYFENDUS, a vaccine for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis; Ebanga, a monoclonal antibody for the treatment of infection caused by Orthoebolavirus zairense; Raxibacumab injection, a monoclonal antibody therapeutic for the treatment and prophylaxis of inhalational anthrax due to Bacillus anthracis; TEMBEXA, an oral antiviral for the treatment of smallpox disease caused by variola virus in adult and pediatric patients; and CNJ-016, a polyclonal antibody therapeutic to address complications from smallpox vaccination. It also provides NARCAN and KLOXXADO nasal sprays for the emergency treatment of known or suspected opioid overdose. In addition, the company offers contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, analytical development, and suite reservation services. Emergent BioSolutions Inc. was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.

Organisation Drug Manufacturers - Specialty & Generic

Employees 900

Industry Drug Manufacturers - Specialty & Generic

CEO Mr. Joseph C. Papa Jr., M.B.A., R.Ph.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Emergent BioSolutions Inc FAQs

What is the share price of Emergent BioSolutions Inc today?

The current share price of Emergent BioSolutions Inc is $8.19.

Can I buy Emergent BioSolutions Inc shares in India?

Yes, Indian investors can buy Emergent BioSolutions Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Emergent BioSolutions Inc shares in India?

You can easily invest in Emergent BioSolutions Inc shares from India by:

Can I buy fractional shares of Emergent BioSolutions Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Emergent BioSolutions Inc?

Emergent BioSolutions Inc has a market cap of $430.14 M.

In which sector does Emergent BioSolutions Inc belong?

Emergent BioSolutions Inc operates in the Drug Manufacturers - Specialty & Generic sector.

What documents are required to invest in Emergent BioSolutions Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Emergent BioSolutions Inc?

The PE ratio of Emergent BioSolutions Inc is 8.71 and the PB ratio is 0.81.